Elevation Oncology to Present at AACR Annual Meeting

(24/7 MARKET NEWS) – Elevation Oncology, Inc. (NASDAQ: ELEV) stated that it will deliver an oral presentation covering preclinical proof-of-concept data for EO-3021 at the New Drugs on the Horizon special session at the American Association for Cancer Research (AACR) Annual Meeting 2023, April 14-19, 2023 in Orlando, Florida.

Elevation Oncology is trading at $1.75, up $0.32 (+22.38%), on 160 thousand shares traded.

Its 52-week trading range is $0.7229 to 4.6099. It’s now trading at price levels last seen in June and, although it may not do it today, if it can maintain this strong trading volume, its setup is favorable to potentially reverse June’s move to $2+.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to or for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist